News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline – Kathi Apostolidis
Photo from Boehringer Ingelheim/Linkedin
Jul 16, 2023, 07:02

Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline – Kathi Apostolidis

This is encouraging news for patients with a very rare cancer, liposarcoma, who had not any new treatment for the last 45years. Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline and get all needed information. 
For details: Click here
Source:
cancer care clinical trial Kathi Apostolidis liposarcoma OncoDaily Oncology rare cancer
Special Coverage
Blog
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Insight
Dec 22, 2024, 17:57
Gustavo Viani: Internal Mammary Node Radiation, A Survival Boost for Breast Cancer Patients?
Insight
Dec 22, 2024, 17:54
Stephen Liu: The seminal IPASS trial in EGFR NSCLC
Insight
Dec 22, 2024, 17:51
Angela Lamarca: eUpdate of ESMO Biliary Malignancies CP Guidelines
Insight
Dec 22, 2024, 17:47
Next-gen immunotherapy is reshaping lung cancer treatment
Insight
Dec 22, 2024, 17:44
Erman Akkus: Local treatments of HCC, 2 recent studies
Blog
Dec 22, 2024, 17:39
Mark Cobbold: Incredible Year in Cell Therapy and Immunotherapy at AstraZeneca
Insight
Dec 22, 2024, 17:36
Nicholas Hornstein: Something new in BRAF V600E mCRC
Insight
Dec 22, 2024, 17:32
Fawzi Abu Rous: We launched Lung Cancer Alliance in Arabic-Speaking MENA
Science
Dec 22, 2024, 17:26
Andrea De Giglio: The prognostic role of STK11 mutations in advanced NSCLC treated with first-line IO
Science
Dec 22, 2024, 17:23
Zeynep Irem Ozay: Assessing nectin-4 as a predictive biomarker in GU malignancies
Science
Dec 22, 2024, 17:18
Sam Klempner: Proof of principle in KRAS G12C mutation in colorectal cancer